Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04202289Phase 3Completed
Phase 3, randomised, open-label trial (2 arms). Primary endpoints: Number of days for complete reepithelialization of the burn wound at Day 11, Number of dressings performed at Day 11 and 2 more. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04202289.